We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bayer HealthCare (BHC) and Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson company, announced today that they have concluded an agreement to jointly develop and market BAY 59-7939 (Factor Xa inhibitor) for the prevention and treatment of thrombosis.
Saudi Arabian regulators have given permission to 14 companies to provide health insurance services, ahead of plans to make health insurance mandatory in January 2006.
According to recent reports, a free trade agreement (FTA) between the United States, Colombia, Ecuador and Peru could be agreed upon by the end of November.
China is aiming to become a leading player in the biotechnology sector by taking advantage of its low research costs, which are up to five times cheaper than in Europe or the US.
Discovery Partners International, Inc. (Nasdaq: DPII -- News) announced today that they have successfully agreed on their collaboration with Ono Pharmaceutical Co., Ltd. DPI will collaborate with Ono on multiple hit-to-lead and lead optimization projects.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, announced today its intention to publicly offer 7,535,913 shares of its common stock of which 6,593,406 are being offered by the Company.
Par Pharmaceutical Cos. said Monday that it agreed to act on behalf of Turkish drug maker MN Pharmaceuticals to file up to 10 Food and Drug Administration marketing applications for generic drugs. Financial terms of the agreement were not disclosed.
BioWa, Inc. and OncoTherapy Science, Inc. today announced that the two companies have entered into a collaboration to identify and develop cancer- focused monoclonal antibodies (Mabs).